These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 7046103
1. The protective effect of clavulanic acid in a combined formulation on the concentration of amoxycillin in the urine of patients with urinary tract infections. Lindeque KP. S Afr Med J; 1982 Jul 28; 62(5 Spec No):12A-13A. PubMed ID: 7046103 [Abstract] [Full Text] [Related]
2. Efficacy and tolerability of an amoxycillin/clavulanic acid combination in the treatment of common bacterial infections. A general practitioner trial. Levenstein JH. S Afr Med J; 1982 Jul 28; 62(5 Spec No):16A-20A. PubMed ID: 7046104 [Abstract] [Full Text] [Related]
3. [Treatment with amoxicillin and clavulanic acid of urinary tract infections in patients with spinal injuries]. Du Plessis DJ, Celliers D, Van Rensburg AJ, Lindeque KP. S Afr Med J; 1982 Jul 28; 62(5 Spec No):8A-11A. PubMed ID: 6979806 [Abstract] [Full Text] [Related]
4. Augmentin (amoxycillin-clavulanic acid) compared with amoxycillin alone in the treatment of urinary tract infections in the elderly. Gallacher G, Erwin L, Scott PJ, Sleigh JD. J Infect; 1986 May 28; 12(3):229-33. PubMed ID: 3522749 [Abstract] [Full Text] [Related]
6. Augmentin treatment of bacterial infections in hospitalised patients. Ellis-Pegler RB, Lang SD, Downey DJ, Anderson MP. N Z Med J; 1982 Aug 11; 95(713):542-5. PubMed ID: 6752781 [Abstract] [Full Text] [Related]
10. [Urinary tract infections in children. Status in a pediatric hospital and sensitivity of bacterial strains to amoxycillin-clavulanic acid combination]. Cochat N, Barbe G, Boutin-Tranchant ME, Cochat P. Pediatrie; 1987 Jul 11; 42(4):309-14. PubMed ID: 3671031 [Abstract] [Full Text] [Related]
12. Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella pneumoniae. Wilkowski P, Hryniewiecka E, Jasińska K, Pączek L, Ciszek M. Ann Transplant; 2023 May 16; 28():e939258. PubMed ID: 37190675 [Abstract] [Full Text] [Related]
13. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study. Van den Ende J, Gricius ME, De Klerk HC, Neiteler BF, Forder AA, Venter L, Hallett AF, Koornhof HJ, Robinson R, Van Rensburg AJ, Lindeque KP. S Afr Med J; 1982 Jul 28; 62(5 Spec No):5A-8A. PubMed ID: 6979805 [Abstract] [Full Text] [Related]
14. Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections. Goldstein FW, Kitzis MD, Acar JF. J Antimicrob Chemother; 1979 Nov 28; 5(6):705-9. PubMed ID: 395156 [No Abstract] [Full Text] [Related]
16. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections. Tan TH, Tay L, Yeo M, Feng PH. Singapore Med J; 1983 Oct 28; 24(5):299-302. PubMed ID: 6669995 [No Abstract] [Full Text] [Related]
17. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers. Ponte C, Gracia M, Giménez MJ, Aguilar L, Maín CM, Carpintero Y, Huelves L, Carcas A, del Prado G, Soriano F. Clin Ther; 2005 Jul 28; 27(7):1043-9. PubMed ID: 16154483 [Abstract] [Full Text] [Related]